Venus Remedies Ltd is an Indian Pharmaceutical company with a presence in domestic and international markets. It is primarily engaged in the business of pharmaceutical products manufacturing. The company manufactures and sells a very wide range of pharmaceutical products in therapeutic segments like Anti-infective (antibiotics), oncology, neurology, pain management, skin & wound care, anti-microbial resistance, etc.
- Venus Remedies Ltd reported Total revenue for Q4 FY23 of ₹156 Crore, up from ₹142 Crore year on year depicting a growth of 10%.
- Total Expenses for Q4 FY23 of ₹131 Crore down, from ₹137 Crore year on year, a decline of 4%.
- Consolidated Net Profit of ₹11 Crore, up 100% from ₹0 Crore in the same quarter of the previous year.
- The Earnings per Share is ₹8.27, up 4,674% from ₹0.17 in the same quarter of the previous year.